These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 32156809)

  • 81. Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex.
    Beck Z; Torres OB; Matyas GR; Lanar DE; Alving CR
    J Control Release; 2018 Apr; 275():12-19. PubMed ID: 29432824
    [TBL] [Abstract][Full Text] [Related]  

  • 82. M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats.
    Vohra H; Dey N; Gupta S; Sharma AK; Kumar R; McMillan D; Good MF
    Res Microbiol; 2005 May; 156(4):575-82. PubMed ID: 15862457
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.
    Schneider-Ohrum K; Cayatte C; Bennett AS; Rajani GM; McTamney P; Nacel K; Hostetler L; Cheng L; Ren K; O'Day T; Prince GA; McCarthy MP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148790
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Improving the efficacy of a prophylactic vaccine formulation against lymphatic filariasis.
    Chauhan N; Banerjee P; Khatri VK; Canciamille A; Gilles J; Kalyanasundaram R
    Parasitol Res; 2017 Oct; 116(10):2821-2830. PubMed ID: 28828575
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Predicted Coverage and Immuno-Safety of a Recombinant C-Repeat Region Based Streptococcus pyogenes Vaccine Candidate.
    McNeilly C; Cosh S; Vu T; Nichols J; Henningham A; Hofmann A; Fane A; Smeesters PR; Rush CM; Hafner LM; Ketheesan N; Sriprakash KS; McMillan DJ
    PLoS One; 2016; 11(6):e0156639. PubMed ID: 27310707
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope.
    Olive C; Clair T; Yarwood P; Good MF
    Vaccine; 2002 Jun; 20(21-22):2816-25. PubMed ID: 12034109
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
    Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
    Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Defense from the Group A Streptococcus by active and passive vaccination with the streptococcal hemoprotein receptor.
    Huang YS; Fisher M; Nasrawi Z; Eichenbaum Z
    J Infect Dis; 2011 Jun; 203(11):1595-601. PubMed ID: 21592989
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.
    Verma V; Tan W; Puth S; Cho KO; Lee SE; Rhee JH
    J Transl Med; 2016 May; 14(1):135. PubMed ID: 27184355
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations.
    Van Hoeven N; Joshi SW; Nana GI; Bosco-Lauth A; Fox C; Bowen RA; Clements DE; Martyak T; Parks DE; Baldwin S; Reed SG; Coler RN
    PLoS One; 2016; 11(2):e0149610. PubMed ID: 26901122
    [TBL] [Abstract][Full Text] [Related]  

  • 91. RLJ-NE-299A: a new plant based vaccine adjuvant.
    Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K
    Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Activity Relationship of Poly(ethylenimine)-Based Liposomes as Group A
    Jin S; Zhang J; Nahar UJ; Huang W; Alharbi NA; Shalash AO; Koirala P; Yang J; Kiong JJE; Khalil ZG; Capon RJ; Stephenson RJ; Skwarczynski M; Toth I; Hussein WM
    ACS Infect Dis; 2023 Aug; 9(8):1570-1581. PubMed ID: 37489053
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluation.
    Younis SY; Barnier-Quer C; Heuking S; Sommandas V; Brunner L; Vd Werff N; Dubois P; Friede M; Kocken C; Collin N; Remarque E
    BMC Immunol; 2018 Jan; 19(1):6. PubMed ID: 29386070
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Self-assembled monovalent lipidated mannose ligand as a standalone nanoadjuvant.
    Nahar UJ; Wang J; Shalash AO; Lu L; Islam MT; Alharbi N; Koirala P; Khalil ZG; Capon RJ; Hussein WM; Toth I; Skwarczynski M
    Vaccine; 2024 Oct; 42(23):126060. PubMed ID: 38897890
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Designing Adjuvant Formulations to Promote Immunogenicity and Protective Efficacy of
    Techawiwattanaboon T; Courant T; Brunner L; Sathean-Anan-Kun S; Krangvichian P; Iadsee N; Nakornpakdee Y; Sangjun N; Komanee P; Collin N; Ruxrungtham K; Patarakul K
    Front Cell Infect Microbiol; 2022; 12():918629. PubMed ID: 35782116
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cross-serotype protection against group A Streptococcal infections induced by immunization with SPy_2191.
    Sanduja P; Gupta M; Somani VK; Yadav V; Dua M; Hanski E; Sharma A; Bhatnagar R; Johri AK
    Nat Commun; 2020 Jul; 11(1):3545. PubMed ID: 32669564
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young mice.
    Vintiñi E; Villena J; Alvarez S; Medina M
    Clin Exp Immunol; 2010 Mar; 159(3):351-62. PubMed ID: 20002449
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine.
    Zaman M; Skwarczynski M; Malcolm JM; Urbani CN; Jia Z; Batzloff MR; Good MF; Monteiro MJ; Toth I
    Nanomedicine; 2011 Apr; 7(2):168-73. PubMed ID: 21034860
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Update on group A streptococcal vaccine development.
    Dale JB; Walker MJ
    Curr Opin Infect Dis; 2020 Jun; 33(3):244-250. PubMed ID: 32304470
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Lipid Nanoparticle with 1,2-Di-O-octadecenyl-3-trimethylammonium-propane as a Component Lipid Confers Potent Responses of Th1 Cells and Antibody against Vaccine Antigen.
    Kawai A; Noda M; Hirata H; Munakata L; Matsuda T; Omata D; Takemura N; Onoe S; Hirose M; Kato T; Saitoh T; Hirai T; Suzuki R; Yoshioka Y
    ACS Nano; 2024 Jul; 18(26):16589-16609. PubMed ID: 38885198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.